Search
Search Results
##search.searchResults.foundPlural##
-
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3620PDF: 1204HTML: 3862Untitled: 185Untitled: 240 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3089PDF: 1099HTML: 1451Untitled: 159Untitled: 147Untitled: 147 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3172PDF: 878HTML: 744text and figure: 206 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1929PDF: 733HTML: 3098 -
-
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1462PDF: 758HTML: 1459Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 160 -
-
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2076PDF: 724HTML: 1015Spirometry in SCA patients before transplant: 182Spirometry in SCA patients post transplant: 163 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
1981PDF: 1162Html: 258 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1257PDF: 1082HTML: 91 -
-
Sickle cell disease and Bartonella spp. infection
1107PDF: 833HTML: 442 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
616PDF: 478HTML: 199 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
1982PDF: 900HTML: 278 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1529PDF: 957HTML: 339 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
985PDF: 930HTML: 298 -
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1033PDF: 468HTML: 8134 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2241PDF: 1539HTML: 576 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
1999PDF: 454HTML: 115 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
926PDF: 932Suppl. Files: 612HTML: 92 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7663PDF: 3969HTML: 7286 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2088PDF: 1131HTML: 2572Study of serum haptoglobin level in thalassemia: 315Figures: 156 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
760PDF: 658HTML: 291 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3300PDF: 1253HTML: 1845Fig.1: 179Fig. 2: 186







